FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.
Saved in:
| Title: | FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. |
|---|---|
| Authors: | Mostafa A; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Kandeil A; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., A M M Elshaier Y; Organic & Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City, Menoufia 32897, Egypt., Kutkat O; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Moatasim Y; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Rashad AA; Department of Biochemistry & Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102, USA., Shehata M; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Gomaa MR; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Mahrous N; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Mahmoud SH; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., GabAllah M; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Abbas H; Department of Microbiology and Immunology, Zagazig University, Zagazig 44519, Egypt., Taweel AE; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Kayed AE; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Kamel MN; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Sayes ME; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Mahmoud DB; Pharmaceutics Department, National Organization for Drug Control and Research, Giza 12654, Egypt., El-Shesheny R; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt., Kayali G; Department of Epidemiology, Human Genetics, and Environmental Sciences, University of Texas, Houston, TX 77030, USA.; Human Link, Baabda 1109, Lebanon., Ali MA; Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt. |
| Source: | Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2020 Dec 04; Vol. 13 (12). Date of Electronic Publication: 2020 Dec 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1424-8247 |
|---|---|
| DOI: | 10.3390/ph13120443 |
